Header Logo

Connection

Paul Ruff to Humans

Back to Details
This is a "connection" page, showing publications Paul Ruff has written about Humans.
Paul Ruff
Connection Strength
1,444
Humans
  1. Barriers and Challenges to Implementing a Quality Improvement Program: Political and Administrative Challenges. JCO Glob Oncol. 2024 Jun; 10:e2300455.
    View in: PubMed
    Score: 0,070
  2. The Looming Threat: Cancer in Sub-Saharan Africa. Oncologist. 2021 12; 26(12):e2099-e2101.
    View in: PubMed
    Score: 0,058
  3. Survival of south african women with breast cancer receiving anti-retroviral therapy for HIV. Breast. 2021 Oct; 59:27-36.
    View in: PubMed
    Score: 0,057
  4. It's contrary - comorbidity does not affect survival of South Africans with colorectal cancer: An analysis from the Colorectal Cancer in South Africa cohort. S Afr Med J. 2020 Apr 29; 110(5):382-388.
    View in: PubMed
    Score: 0,053
  5. Colorectal Cancer (CRC) treatment and associated costs in the public sector compared to the private sector in Johannesburg, South Africa. BMC Health Serv Res. 2020 Apr 07; 20(1):290.
    View in: PubMed
    Score: 0,053
  6. A Prospective Cohort Study of Factors Associated With Place of Death Among Patients With Late-Stage Cancer in Southern Africa. J Pain Symptom Manage. 2019 05; 57(5):923-932.
    View in: PubMed
    Score: 0,049
  7. Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV. Breast. 2019 Feb; 43:123-129.
    View in: PubMed
    Score: 0,048
  8. Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11. Cancer Epidemiol. 2018 02; 52:120-127.
    View in: PubMed
    Score: 0,045
  9. Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial. J Geriatr Oncol. 2018 01; 9(1):32-39.
    View in: PubMed
    Score: 0,044
  10. Access to Cancer Therapeutics in Low- and Middle-Income Countries. Am Soc Clin Oncol Educ Book. 2016; 35:58-65.
    View in: PubMed
    Score: 0,039
  11. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. Eur J Cancer. 2015 Jan; 51(1):18-26.
    View in: PubMed
    Score: 0,036
  12. The South African National Cancer Registry: an update. Lancet Oncol. 2014 Aug; 15(9):e363.
    View in: PubMed
    Score: 0,036
  13. Cancer care in South Africa. Lancet Oncol. 2012 Aug; 13(8):e324.
    View in: PubMed
    Score: 0,031
  14. Brief communication: Minimally invasive bone sampling method for DNA analysis. Am J Phys Anthropol. 2009 Aug; 139(4):596-9.
    View in: PubMed
    Score: 0,025
  15. A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen. Cancer Chemother Pharmacol. 2009 Sep; 64(4):763-8.
    View in: PubMed
    Score: 0,024
  16. The South African Bone Marrow Registry (SABMR) and allogeneic bone marrow transplantation. S Afr Med J. 2008 Jul; 98(7):516, 518, 520.
    View in: PubMed
    Score: 0,023
  17. The association of HIV status with triple-negative breast cancer in patients with breast cancer in South Africa: a cross-sectional analysis of case-only data from a prospective cohort study. Lancet Glob Health. 2024 Dec; 12(12):e1993-e2002.
    View in: PubMed
    Score: 0,018
  18. Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study. PLoS One. 2024; 19(11):e0309778.
    View in: PubMed
    Score: 0,018
  19. Perspectives on common chronic diseases in adult cancer patients in South Africa. Glob Health Action. 2023 12 31; 16(1):2228567.
    View in: PubMed
    Score: 0,017
  20. FGFR2 genetic variants in women with breast cancer. Mol Med Rep. 2023 Dec; 28(6).
    View in: PubMed
    Score: 0,017
  21. The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer. Oncologist. 2023 10 03; 28(10):e921-e929.
    View in: PubMed
    Score: 0,017
  22. Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa. Cancer Med. 2023 07; 12(14):15515-15529.
    View in: PubMed
    Score: 0,016
  23. PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients-a South African cohort study. Breast Cancer Res Treat. 2023 Aug; 200(3):337-346.
    View in: PubMed
    Score: 0,016
  24. Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co-Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer. Clin Pharmacol Ther. 2023 07; 114(1):127-136.
    View in: PubMed
    Score: 0,016
  25. Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer. Breast Cancer Res Treat. 2023 May; 199(1):1-12.
    View in: PubMed
    Score: 0,016
  26. Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort. PLoS One. 2023; 18(2):e0281916.
    View in: PubMed
    Score: 0,016
  27. Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study. Breast Cancer Res. 2023 01 23; 25(1):7.
    View in: PubMed
    Score: 0,016
  28. The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa. Breast Cancer Res Treat. 2023 Feb; 197(3):647-659.
    View in: PubMed
    Score: 0,016
  29. Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men. Cancer Epidemiol Biomarkers Prev. 2022 12 05; 31(12):2192-2198.
    View in: PubMed
    Score: 0,016
  30. Burn-injured patients - the preferably unheard. S Afr J Surg. 2022 Dec; 60(4):229-234.
    View in: PubMed
    Score: 0,016
  31. The Impact of Breast Cancer Treatment Delays on Survival Among South African Women. Oncologist. 2022 03 11; 27(3):e233-e243.
    View in: PubMed
    Score: 0,015
  32. Impact of HIV infection on survival among women with stage I-III breast cancer: Results from the South African breast cancer and HIV outcomes study. Int J Cancer. 2022 Jul 15; 151(2):209-221.
    View in: PubMed
    Score: 0,015
  33. Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals. JCO Glob Oncol. 2021 12; 7:1730-1741.
    View in: PubMed
    Score: 0,015
  34. Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care. JCO Glob Oncol. 2021 09; 7:1513-1521.
    View in: PubMed
    Score: 0,015
  35. Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa. Breast Cancer Res Treat. 2021 Aug; 189(1):285-296.
    View in: PubMed
    Score: 0,014
  36. Cancer and COVID-19 Experiences at African Cancer Centers: The Silver Lining. JCO Glob Oncol. 2021 03; 7:410-415.
    View in: PubMed
    Score: 0,014
  37. Consensus study on the health system and patient-related barriers for lung cancer management in South Africa. PLoS One. 2021; 16(2):e0246716.
    View in: PubMed
    Score: 0,014
  38. Quality of Histopathological Reporting in Breast Cancer: Results From Four South African Breast Units. JCO Glob Oncol. 2021 01; 7:72-80.
    View in: PubMed
    Score: 0,014
  39. Quality indicators for the diagnosis and surgical management of breast cancer in South Africa. Breast. 2020 Dec; 54:187-196.
    View in: PubMed
    Score: 0,014
  40. Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab monotherapy. Cancer Biol Ther. 2020 10 02; 21(10):891-898.
    View in: PubMed
    Score: 0,014
  41. A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection. Breast Cancer Res Treat. 2020 Dec; 184(3):861-872.
    View in: PubMed
    Score: 0,014
  42. Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer. Gynecol Oncol. 2020 10; 159(1):142-149.
    View in: PubMed
    Score: 0,013
  43. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV. BMC Gastroenterol. 2020 Jul 13; 20(1):226.
    View in: PubMed
    Score: 0,013
  44. Spiritual Care, Pain Reduction, and Preferred Place of Death Among Advanced Cancer Patients in Soweto, South Africa. J Pain Symptom Manage. 2020 07; 60(1):37-47.
    View in: PubMed
    Score: 0,013
  45. Breast Cancer Care Quality in South Africa's Public Health System: An Evaluation Using American Society of Clinical Oncology/National Quality Forum Measures. J Glob Oncol. 2019 11; 5:1-16.
    View in: PubMed
    Score: 0,013
  46. The multimorbidity profile of South African women newly diagnosed with breast cancer. Int J Cancer. 2020 07 15; 147(2):361-374.
    View in: PubMed
    Score: 0,013
  47. Exon skipping truncates the PDZ domain of human erythroid p55 in a patient with chronic myeloid leukemia in acute megakaryoblastic blast crisis. Leuk Res. 1999 Mar; 23(3):247-50.
    View in: PubMed
    Score: 0,012
  48. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression. Microrna. 2019; 8(1):68-75.
    View in: PubMed
    Score: 0,012
  49. Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy. Oncologist. 2019 07; 24(7):933-944.
    View in: PubMed
    Score: 0,012
  50. Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study. Clin Cancer Res. 2019 02 15; 25(4):1216-1225.
    View in: PubMed
    Score: 0,012
  51. Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. J Glob Oncol. 2018 09; 4:1-9.
    View in: PubMed
    Score: 0,012
  52. Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 2018; 107(3):237-245.
    View in: PubMed
    Score: 0,012
  53. Informal Caregiver Challenges for Advanced Cancer Patients During End-of-Life Care in Johannesburg, South Africa and Distinctions Based on Place of Death. J Pain Symptom Manage. 2018 07; 56(1):98-106.
    View in: PubMed
    Score: 0,011
  54. Barriers to early presentation of breast cancer among women in Soweto, South Africa. PLoS One. 2018; 13(2):e0192071.
    View in: PubMed
    Score: 0,011
  55. A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma. Ann Oncol. 1998 Feb; 9(2):217-9.
    View in: PubMed
    Score: 0,011
  56. Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa. PLoS One. 2017; 12(8):e0182125.
    View in: PubMed
    Score: 0,011
  57. Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer. Eur J Cancer. 2016 11; 68:51-59.
    View in: PubMed
    Score: 0,010
  58. Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy. Target Oncol. 2016 06; 11(3):383-400.
    View in: PubMed
    Score: 0,010
  59. Molecular analysis of a silent polymorphism in the PDZ domain of p55, the major palmitoylated erythrocyte membrane protein. Hematopathol Mol Hematol. 1996; 10(4):187-91.
    View in: PubMed
    Score: 0,010
  60. Establishment of a cancer surveillance programme: the South African experience. Lancet Oncol. 2015 Aug; 16(8):e414-21.
    View in: PubMed
    Score: 0,010
  61. Patterns of clonal evolution in transformed chronic myelogenous leukemia. Cancer Genet Cytogenet. 1995 Jun; 81(2):182-4.
    View in: PubMed
    Score: 0,009
  62. Lymphoproliferative malignancies in association with endemic African Kaposi's sarcoma. Cent Afr J Med. 1994 Jul; 40(7):176-8.
    View in: PubMed
    Score: 0,009
  63. ASPECCT: panitumumab versus cetuximab for colorectal cancer--authors' reply. Lancet Oncol. 2014 Jul; 15(8):e303.
    View in: PubMed
    Score: 0,009
  64. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study. Lancet Oncol. 2014 May; 15(6):569-79.
    View in: PubMed
    Score: 0,009
  65. Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study Group. Oncology. 1994 Jan-Feb; 51(1):113-8.
    View in: PubMed
    Score: 0,009
  66. Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial. Eur J Cancer. 2014 Jan; 50(2):320-31.
    View in: PubMed
    Score: 0,008
  67. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013 Sep 12; 369(11):1023-34.
    View in: PubMed
    Score: 0,008
  68. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol. 2012 Oct 01; 30(28):3499-506.
    View in: PubMed
    Score: 0,008
  69. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol. 2010 Nov 01; 28(31):4697-705.
    View in: PubMed
    Score: 0,007
  70. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009 Apr 02; 360(14):1408-17.
    View in: PubMed
    Score: 0,006
  71. Novel methods of molecular sex identification from skeletal tissue using the amelogenin gene. Forensic Sci Int Genet. 2009 Mar; 3(2):74-9.
    View in: PubMed
    Score: 0,006
  72. The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Int J Cancer. 2008 May 15; 122(10):2260-5.
    View in: PubMed
    Score: 0,006
  73. Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. J Clin Oncol. 2007 Jul 20; 25(21):3069-75.
    View in: PubMed
    Score: 0,005
  74. Amyloidosis: a changing clinical perspective. Hematology. 2007 Apr; 12(2):163-7.
    View in: PubMed
    Score: 0,005
  75. A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy. Int J Gynecol Cancer. 2006 Jul-Aug; 16(4):1614-9.
    View in: PubMed
    Score: 0,005
  76. Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer. BMC Cancer. 2004 Jul 16; 4:36.
    View in: PubMed
    Score: 0,004
  77. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study. BMC Infect Dis. 2003 Sep 12; 3:21.
    View in: PubMed
    Score: 0,004
  78. The treatment of AIDS-related cancers. Lancet Oncol. 2003 Sep; 4(9):576-81.
    View in: PubMed
    Score: 0,004
  79. Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells. Anticancer Res. 2002 Jul-Aug; 22(4):2253-9.
    View in: PubMed
    Score: 0,004
  80. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer. 2000 Nov 01; 88(3):489-92.
    View in: PubMed
    Score: 0,003
  81. Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am J Clin Oncol. 1997 Dec; 20(6):605-8.
    View in: PubMed
    Score: 0,003
  82. Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. Br J Cancer. 1997; 75(11):1704-7.
    View in: PubMed
    Score: 0,003
  83. SSCP analysis of the tyrosine kinase domain of the insulin receptor gene: polymorphisms detected in South African black and white subjects. Hum Genet. 1996 Apr; 97(4):438-40.
    View in: PubMed
    Score: 0,002
  84. Radiation therapy in an elderly African population with Kaposi's sarcoma. Tumori. 1994 Apr 30; 80(2):139-40.
    View in: PubMed
    Score: 0,002
  85. Radiation therapy in endemic (African) Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1993 Dec 01; 27(5):1181-4.
    View in: PubMed
    Score: 0,002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.